chevron_leftBack
As of 24 April 2025, SEED Co.,Ltd. has a market cap of $100.68M USD, ranking #20678 globally and #2138 in Japan. It ranks #2056 in the Healthcare sector, and #165 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$100.68MUSD
14.35B JPY
Enterprise Value
$230.24MUSD
32.95B JPY
Revenue (TTM)
$234.79MUSD
33.46B JPY
EBITDA (TTM)
$33.53MUSD
4.8B JPY
Net Income (TTM)
$10.91MUSD
1.56B JPY
EBITDA Margin
14%
Profit Margin
4.6%
PE Ratio
8.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Masahiro Urakabe
open_in_new
Employees
962
Founded
1957
Website
seed.co.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | 3.5% | -10% | -4.2% | -4.4% | -19% |
Upcoming Earnings
Earnings Date
Mon, May 12
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
7743
株式会社シード
ISIN: JP3347000006
Shares Out.:
Shares Outstanding:
30.266M1
Shares Float:
14.334M2
|
470 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SEED Co.,Ltd.
SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal contact lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyPure moisture, SEED MonthlyFine UV, and monthly color lens UV replacement contact lenses; Forest Leaf EX cleaning solution; rigid gas permeable contact lenses; and medical contact lenses, including orthokeratology and iris lens. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, Plusmix, etc brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products. The company was incorporated in 1957 and is headquartered in Tokyo, Japan.
